Opportunity Information: Apply for RFA OAA 10 000007
Apply for RFA OAA 10 000007
- The Agency for International Development in the health sector is offering a public funding opportunity titled "Control of Neglected Tropical Diseases" and is now available to receive applicants.
- This funding opportunity was created on Jun 15, 2010 and posted on May 7, 2010.
- Applicants must submit their applications by Jun 30, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $450,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $450,000,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses.
- To be eligible for the Cooperative Agreement under this RFA, an organization must 1. Be a U.S. or non U.S. based institution, for profit, non profit, or private voluntary organization 2. Have experience and/or capacity in awarding and administering grants (Tracks 1 and 2) and working in the area of NTDs described in this RFA (Track 1 only) 3. Agree to work with and hire individuals that have managerial expertise in managing grants (Tracks 1 and 2) and technical expertise in the NTDs described in this RFA (Track 1 only) 4. Have managerial, technical and institutional capacities to achieve the results outlined in this RFA and, 5. Have the capacity to collaborate with other organizations/groups to mobilize resources and disseminate best practices.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This USAID grant opportunity, titled "Control of Neglected Tropical Diseases" (Funding Opportunity Number RFA-OAA-10-000007), is a large-scale global health initiative aimed at reducing the burden of seven major neglected tropical diseases (NTDs) that disproportionately affect the poorest and most rural communities in the developing world. The core problem the program targets is that more than one billion people live with one or more NTDs, often in places where access to safe water, sanitation, and essential medicines is limited. These diseases create long-term illness and disability, worsen childhood malnutrition, interfere with childrens physical and cognitive development, and can lead to severe outcomes such as blindness, major disfigurement, and significant productivity losses that reinforce cycles of poverty.
USAID plans to make three awards using a cooperative agreement mechanism, meaning the agency expects to have substantial involvement in the design, coordination, and oversight of the work rather than simply issuing a grant with minimal ongoing engagement. The activity area is health, and the strategy emphasized throughout the announcement is integrated disease control using preventive chemotherapy (PCT). PCT is a cost-effective public health approach that delivers safe, highly effective medicines at scale, often through mass drug administration campaigns, to prevent and treat infections across entire at-risk populations. A notable feature of this program is that many of the drugs used for these NTDs are donated by major pharmaceutical companies, which allows programs to focus resources on delivery systems, training, monitoring, and the logistics needed to reach large populations consistently.
The seven diseases covered are lymphatic filariasis (elephantiasis), onchocerciasis (river blindness), schistosomiasis (snail fever), three soil-transmitted helminth infections (hookworm, roundworm, and whipworm), and trachoma. The RFA stresses that these conditions can be prevented and/or cured in an integrated fashion, which reflects an intent to support programs that coordinate interventions rather than running separate, disease-by-disease vertical campaigns. In practice, that typically means combining drug distribution platforms, using shared community-based delivery networks, coordinating mapping and surveillance, and aligning monitoring and evaluation so that countries and implementing partners can achieve broader coverage at lower cost.
Financially, the opportunity is substantial. The estimated total funding listed is $450,000,000, with an award ceiling also stated as $450,000,000 and an award floor of $0, indicating wide flexibility in individual award size depending on the proposed scope and USAIDs allocation decisions across the three anticipated awards. Cost sharing or matching is required, so applicants are expected to contribute non-federal resources (cash and/or in-kind, depending on the terms) to support implementation and demonstrate commitment and leverage. The posting date is May 7, 2010, with a current closing date of June 30, 2010 (the original closing date was June 18, 2010), which shows the application window was extended.
Eligibility is broad but capability-driven. Eligible applicants include U.S. and non-U.S. entities and may be for-profit or nonprofit organizations, including private voluntary organizations; nonprofits with 501(c)(3) status are explicitly listed among eligible applicant categories, as are for-profit organizations other than small businesses. Beyond basic organizational type, the RFA emphasizes demonstrated experience and capacity in grant awarding and administration (referenced as Tracks 1 and 2), as well as specific technical experience with NTD programming for Track 1. Applicants must also be willing to work with and hire personnel who bring strong managerial expertise for grant management and, where applicable, technical expertise in the targeted NTDs. In addition, organizations must show they have the managerial, technical, and institutional capacity to achieve the results USAID outlines, and they must be able to collaborate effectively with other organizations and groups to mobilize resources and share best practices. In other words, the ideal implementer is positioned not only to run field operations but also to manage subawards, coordinate multi-partner delivery systems, and contribute to broader learning and scale-up across countries.
Overall, the opportunity is designed to support large, coordinated NTD control programs that can rapidly expand coverage of proven interventions, particularly mass treatment approaches, while strengthening the systems needed to plan campaigns, manage donated commodities, train and supervise distributors, track coverage, and measure impact. The intent is not simply short-term treatment but measurable reduction in disease burden and the downstream economic and social harms these infections cause in the worlds poorest communities.
For application access issues or administrative questions, the listed contact is Patricia Bradley, Contract/Agreement Specialist at USAID, reachable by phone at 202-712-5421 or email at pbradley@usaid.gov.
FAQs: USAID "Control of Neglected Tropical Diseases" (RFA-OAA-10-000007)
What is this funding opportunity?
This is a USAID grant opportunity titled "Control of Neglected Tropical Diseases" under Funding Opportunity Number RFA-OAA-10-000007. It is a large-scale global health initiative focused on reducing the burden of neglected tropical diseases (NTDs), especially in the poorest and most rural communities in the developing world.
What problem is USAID trying to address through this program?
The opportunity targets the reality that more than one billion people live with one or more NTDs, often in settings with limited access to safe water, sanitation, and essential medicines. These diseases can cause long-term illness and disability, worsen childhood malnutrition, interfere with childrens physical and cognitive development, and lead to outcomes like blindness, major disfigurement, and significant productivity losses that reinforce cycles of poverty.
Which diseases are included in this program?
The RFA covers seven major NTDs:
- Lymphatic filariasis (elephantiasis)
- Onchocerciasis (river blindness)
- Schistosomiasis (snail fever)
- Soil-transmitted helminth infections: hookworm, roundworm, and whipworm
- Trachoma
What type of award will USAID make?
USAID expects to use a cooperative agreement mechanism. This means USAID anticipates substantial involvement in the design, coordination, and oversight of the work, rather than issuing a grant with minimal ongoing engagement.
How many awards does USAID plan to make?
USAID plans to make three awards under this opportunity.
How much funding is available under this opportunity?
The estimated total funding amount is $450,000,000. The award ceiling is also listed as $450,000,000, and the award floor is $0, which signals flexibility in individual award size depending on the proposed scope and how USAID allocates funding across the three anticipated awards.
Is cost sharing or matching required?
Yes. Cost sharing or matching is required, meaning applicants are expected to contribute non-federal resources to support implementation and demonstrate commitment and leverage.
What technical strategy does the RFA emphasize?
The announcement emphasizes integrated disease control using preventive chemotherapy (PCT). PCT is described as a cost-effective public health approach that delivers safe, highly effective medicines at scale, often through mass drug administration campaigns, to prevent and treat infections across at-risk populations.
What does "integrated" NTD control mean in this RFA?
In this opportunity, integration refers to preventing and/or curing the covered conditions in a coordinated way rather than running separate, disease-by-disease vertical campaigns. In practice, this typically involves combining drug distribution platforms, using shared community-based delivery networks, coordinating mapping and surveillance, and aligning monitoring and evaluation to achieve broader coverage at lower cost.
Why does the RFA mention donated medicines?
The program highlights that many of the drugs used for these NTDs are donated by major pharmaceutical companies. This allows programs to focus more of their resources on delivery systems, training, monitoring, and the logistics needed to reach large populations consistently.
What kinds of activities are implied as priorities for funded programs?
Based on the description, the opportunity is designed to support programs that can rapidly expand coverage of proven interventions (particularly mass treatment approaches) while strengthening systems needed to plan campaigns, manage donated commodities, train and supervise distributors, track coverage, and measure impact.
Is this opportunity limited to U.S. organizations?
No. Eligibility is broad and includes both U.S. and non-U.S. entities.
Are for-profit organizations eligible to apply?
Yes. The RFA states that eligible applicants may be for-profit or nonprofit organizations, including for-profit organizations other than small businesses.
Are nonprofit organizations eligible to apply?
Yes. Eligible applicants include nonprofit organizations, and nonprofits with 501(c)(3) status are explicitly listed.
What capabilities does USAID emphasize for applicants?
Beyond organizational type, USAID emphasizes demonstrated experience and capacity in grant awarding and administration (referenced as Tracks 1 and 2). For Track 1, the RFA also calls for specific technical experience with NTD programming. Applicants are expected to show managerial, technical, and institutional capacity to achieve USAIDs outlined results and to collaborate effectively with other organizations to mobilize resources and share best practices.
What is the expectation around staffing and expertise?
Applicants must be willing to work with and hire personnel who bring strong managerial expertise for grant management and, where applicable, technical expertise in the targeted NTDs.
Does the RFA encourage partnerships and coordination?
Yes. The opportunity describes an implementer that can collaborate effectively with other organizations and groups, coordinate multi-partner delivery systems, manage subawards, and contribute to broader learning and scale-up across countries.
What is the application timeline?
The posting date is May 7, 2010. The current closing date is June 30, 2010, and the original closing date was June 18, 2010, indicating the application window was extended.
Who can I contact for application access issues or administrative questions?
The listed contact is Patricia Bradley, Contract/Agreement Specialist at USAID. Phone: 202-712-5421. Email: pbradley@usaid.gov.
Browse more opportunities from the same category: Health
Next opportunity: Embassy Kabul PAS Annual Program Statement
Previous opportunity: Region 8 Indoor Air Quality Projects, FY 2011/2012
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA OAA 10 000007
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA OAA 10 000007) also looked into and applied for these:
| Funding Opportunity |
|---|
| SSA Retirement Research Consortium Apply for SSA OAG 10 2 Funding Number: SSA OAG 10 2 Agency: Social Security Administration Category: Health Funding Amount: $2,750,000 |
| SSA Financial Literacy Research Consortium Apply for SSA OAG 10 3 Funding Number: SSA OAG 10 3 Agency: Social Security Administration Category: Health Funding Amount: $4,000,000 |
| Reducing Teen Pregnancy through Family Planning Integrating Services, Programs, and Strategies through Community wide Initiatives Apply for CDC RFA DP10 1025 Funding Number: CDC RFA DP10 1025 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Frontier Community Health Integration Demonstration Program Apply for HRSA 10 208 Funding Number: HRSA 10 208 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Patient Navigator Outreach and Chronic Disease Prevention Program Apply for HRSA 10 209 Funding Number: HRSA 10 209 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Domestic Violence Prevention Initiative Apply for HHS 2010 IHS BHDV 0001 Funding Number: HHS 2010 IHS BHDV 0001 Agency: Indian Health Service Category: Health Funding Amount: $52,400 |
| Sexual Assault Projects Expansion Community Developed Models Apply for HHS 2010 IHS BHSA 0001 Funding Number: HHS 2010 IHS BHSA 0001 Agency: Indian Health Service Category: Health Funding Amount: $52,400 |
| Act Against AIDS Leadership Initiative (AAALI) Apply for CDC RFA PS10 1057 Funding Number: CDC RFA PS10 1057 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $120,000 |
| Part D Coordinated HIV Services and Access to Research for Women, Infant, Children and Youth Apply for HRSA 10 203 Funding Number: HRSA 10 203 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Skin Diseases Research Core Centers (P30) Apply for RFA AR 11 010 Funding Number: RFA AR 11 010 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| State Implementation Grants for Improving Services for Children and Youth with with Autism Spectrum Disorder (ASD) and other Developmental Disabilities. Apply for HRSA 10 097 Funding Number: HRSA 10 097 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Rheumatic Diseases Research Core Centers (P30) Apply for RFA AR 11 001 Funding Number: RFA AR 11 001 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| NINDS PHASE III Investigator Initiated Multi Site Clinical Trials (U01) Apply for PAR 10 198 Funding Number: PAR 10 198 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory Clinical Trials (R01) Apply for PAR 10 199 Funding Number: PAR 10 199 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Program to Eliminate Diabetes Related Disparities in Vulnerable Populations Apply for CDC RFA DP 10 1001 Funding Number: CDC RFA DP 10 1001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| Innovative Strategies for Serving Children and Youth with Epilepsy (Project Access) Apply for HRSA 10 147 Funding Number: HRSA 10 147 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| 2010 Leadership Education in Neurodevelopmental and Other Related Disabilities (LEND) Planning Grants Apply for HRSA 10 196 Funding Number: HRSA 10 196 Agency: Health Resources and Services Administration Category: Health Funding Amount: $150,000 |
| NIGMS National Centers for Systems Biology (P50) Apply for PAR 10 200 Funding Number: PAR 10 200 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Pakistan FELTP Human/Animal Disease Investigation and Technical Assistance to the Ministry of Food, Agriculture, and Livestock Apply for CDC RFA GH10 1002 Funding Number: CDC RFA GH10 1002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| The Central Processing of Taste Information (R01) Apply for PA 10 201 Funding Number: PA 10 201 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA OAA 10 000007", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.